title: [Revision of treatment with gemtuzumab ozogamicin using 3 clinical case studies].
authors.forename: E
authors.initials: E
authors.lastname: Fernández Cañabate
authors.forename: M
authors.initials: M
authors.lastname: Longoni Merino
authors.forename: C
authors.initials: C
authors.lastname: Estany Raluy
authors.forename: R
authors.initials: R
authors.lastname: Pla Poblador
mesh_terms: D000293:Adolescent; D000328:Adult; D000617:Aminoglycosides / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000079982:Gemtuzumab; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000079982:Gemtuzumab